DOI: 10.35556/idr-2019-4(89)52-58.
Microbial contamination dynamics in surgical treatment of patients using dental implants in a limited bone tissue volume

Tsitsiashvili A.M., Panin A.M., Nikolayeva Ye.N., Arutyunyan A.A., Podporin M.S., Tsarev V.N.

Federal State Budgetary Educational Institution of Higher Education “A.I. Yevdokimov Moscow State University of Medicine and Dentistry” of the Ministry of Healthcare of the Russian Federation
Russia, 127473, Moscow, Delegatskaya St., 20, bld.1

E-mail address:

The aim of the study was to evaluate the effectiveness of antibiotic chemotherapy regimens and the dynamics of the nature of microbial associations of the operating area at the surgical stages of treatment of patients using dental implants in conditions of limited bone tissue. The study involved 37 patients (17 m and 20 w, from 32 to 68 years). According to the tactics of the treatment and the type of antibacterial effect, the patients were divided into 3 groups. Per os was prescribed antibiotics as a step therapy: amoxicillin (flemoxin 500 mg 1 tablet 2 per day for 7 days) and amoxicillin / clavulanate (flemoclav 625 mg 1 table 2 per day 7 days), doxycycline (unidox 100 mg 1 table 1 per day 5 days). The 1st group of patients (n1=12; 31.9%) — a multi-stage approach (MA), where the 1st operation is bone grafting (BG) (Flemoxin 500 mg), after 6—9 months, the 2nd dental implantation (DI) (flemoklav 625 mg), after 3—6 months the 3rd — installation of gingival formers (GF) (unidox 100 mg). The 2nd group of patients (n2=14; 36.2%) — a one-stage approach (OA), where the 1st operation is BG with simultaneous DI (flemoxin 500 mg), after 6—9 months — the 2nd — installation of GF (flemoklav 625 mg). 3rd group — narrow/short implants (N/S) without BG were installed (n3=11; 31.9%). The 1st operation — DI (Flemoxin 500 mg), the 2nd — installation of GF (Flemoklav 625 mg). A bacteriological study with the identification of pure cultures of bacteria and determination of sensitivity to antibacterial drugs was performed for all patients before treatment and in dynamics. In MA, there was a suppression of the growth of certain types of bacteria and an increase in the number of species resistant to this antibiotic. In the framework of the OA, when prescribing antibiotics, the results were comparable. With N/S implants, growth inhibition of a number of species present at the beginning of treatment was noted. In multi-stage operations, we consider it reasonable to use beta-lactamase-protected drugs, or drugs of another group that include representatives of parodontopathogenic species and potential carriers of multiple resistance genes in their spectrum of action.

Keywords: dental implant, bone grafting, antibiotics, antibiotic resistance.

For citation: Tsitsiashvili A.M., Panin A.M., Nikolayeva Ye.N., Arutyunyan A.A., Podporin M.S., Tsarev V.N. Microbial contamination dynamics in surgical treatment of patients using dental implants in a limited bone tissue volume. Stomatology for All / Int. Dental Review. 2019; No.4(89); 52-58 (In Russian). doi: 10.35556/idr-2019-4(89)52-58

1. Gilbert D.N., Robert S. Antimicrobial therapy. Stanford Handbook. Moscow: EKSMO, 2009, 24 p. (In Russian).
2. Gostishchev V.K. General surgery: a textbook. Moscow: GEOTAR-Media, 2010, 848 p. (In Russian).
3. Eryukhin I.A., Gelfand B.R., Shlyapnikov S.A. Surgical infections. A practical guide. Ed. 2nd, rev. and add. Moscow: Litterra, 2006, 736 p. (In Russian)
4. Zakirov T.V., Voroshilina E.S., Brusnitsyna I.V., Ioshchenko E.S., Ozhgikhina N.V. Evaluation of the effectiveness of the main systemic antibiotics at the first stage of treatment of generalized aggressive periodontitis. Periodontology. 2019 24; No. 3: 213—221 (In Russian). doi: 10.33925 / 1683-3759-2019-24-3-213-221
5. Zueva A.O., Chuvilkin V.I., Podorin M.S., La-Bazanov A.A. et al. Microbiological evaluation of fluoroquinolones of the II and III generations for the prevention and treatment of infectious complications of surgical operations. Bacteriology. 2017; No. 4 (2): 50—54 (In Russian). doi: 10.20953 / 2500-1027-2017-4-50-54
6. Ippolitov E.V. Monitoring the formation of microbial biofilms and optimizing the diagnosis of inflammatory periodontal diseases: abstract. dis. … DMSc. Sechenovskiy University (03.02.03. — Microbiology, 03.14.09. — Immunology). M., 2016, 48 p. (In Russian).
7. Kovalevsky A.M., Ushakova A.V., Kovalevsky V.A., Progerina E.Yu. Bacterial biofilm of periodontal pockets: rethinking the experience of periodontology. Periodontology. 2018; 23; No. 2 (87): 18—21 (In Russian). doi: 10.25636 / PMP.1.2018.2.3
8. Kulakov A.A., Butova V.G., Snurnitsyna Z.A., Kulikova A.N. Provision of the population with the staff of doctors in the profile of “maxillofacial surgery” Dentistry. 2018; No. 1: 4—8 (In Russian). doi: 10.17116 / stomat20189714-8
9. Lomakin M.V., Soloshchansky I.I., Druzhinin A.E. Antibiotic prophylaxis in surgical dental interventions. Russian dentistry. 2012; 5 (4): 25—28 (In Russian).
10. Pankratov A.S., Lekishvili M.V. Osteoplasty in dentistry and maxillofacial surgery. Moscow: BINOM, 2011, 272 (In Russian).
11. Petruk I.V., Eliseeva E.V., Poddubny E.A., Kropotov A.V. Problems of using antibacterial drugs with dental implantation. Pacific Medical Journal. 2019 2: 51—54 (In Russian).–54
12. Ushakov R.V., Tsarev V.N. Antimicrobial therapy in dentistry. Moscow: Practical Medicine, 2019, 240 pp. (In Russian).
13. Tsarev V.N., Ippolitov E.V., Nikolaeva E.N. Distribution of genetic markers of antibiotic resistance in biofilm-forming strains of obligate and facultative anaerobes. Journal of Microbiology, Epidemiology and Immunobiology. 2017; No. 2: 74—80 (In Russian).
14. Hake S.K., Mayer D.H., Theaves-Taylor P.M. Periodontal disease. In: Microbiology and immunology for dentists. Ed. R.J. Lamont, R.A. Burne, M.S. Lantz, D.J. LeBlank. Moscow: Practical medicine. 2010: 297—339 (In Russian).
15. Tsitsiashvili A.M., Panin A.M., Shishkanov A.V. Assessment of the “trauma” of reconstructive operations in the alveolar ridge / part of the jaw. Russian Bulletin of Dental Implantology. 2017; 3—4 (37—38): 33—36 (In Russian).
16. Chuvilkin V.I., Chuvilkina E.I., Tsarev V.N., Shirokov Yu.E. Antibacterial prophylaxis in osteoplastic surgery and dental implantation. Dentistry. 2013; 3: 84—87 (In Russian).
17. Yakovleva S.V., Briko N.I., Sidorenko S.V., Protsenko D.N. The ATCS program (antimicrobial therapy control strategy) in the provision of inpatient care. Russian clinical recommendations. Moscow: Pero, 2018, 156 p. (In Russian)/
18. Yanushevich O.O., Akhmedov G.D., Panin A.M., Arutyunov S.D., Tsarev V.N. Microecology of the oral cavity and infectious and inflammatory complications in surgical dentistry (monograph). Moscow: Practical medicine, 2019, 192 p. (In Russian).
19. Bulletin of the World Health Organization 2017; 95: 599-603. doi:
20. Cullum D., Deporter D. Minimally Invasive Dental Implant Surgery. Wiley Blackwell 2015; 464.
21. Esposito M., Cannizzaro G., Bozzoli P. et al. Effi-cacy of prophylactic antibiotics for dental implants: a multicentre placebo-controlled randomized clinical trial. Eur. J. Oral Implantol.,, 2008; 1 (1): 23-31.
22. Lee J.W., Lee J.Y., Kim S.M., et al. Prophylactic antibiotics in intra-oral bone grafting procedures: a pro-spective, randomized, double-blind clinical trial. J Kor Assoc Oral Maxillofac Surg. 2012; 38: 90—95.
23. Sanz M., Beighton D., Curtis M.A., Cury J.A., Dige I., Dommisch H., Ellwood R., Giacaman R.A., Herrera D., Herzberg M.C., et al. Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of group 1 of the joint EFP / ORCA workshop on the boundaries between caries and periodontal disease. J. Clin. Periodontol. 2017; 44 (Suppl. 18): 5—11. doi: 10.1111 / jcpe.12682
24. Wismeijer D., Chen S., Buser D. (editors) ITI Treatment Guide, Vol 7: Ridge Augmentation Procedures in Implant Patients: A Staged Approach. Quintessence pub 2014; 232.